CD9 and cancer: By applying a RNA sequencing (RNA-seq) approach, we found that the expression of only 15 transcripts was altered upon short exposure (4.5 h) of MSCs to EVs derived from cancer FEMX-I cells, but not (or to a lesser extent) to CD9-depleted EVs (Figure 6F).